Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Adipocyte iron regulates adiponectin and insulin sensitivity
J. Scott Gabrielsen, … , William T. Cefalu, Donald A. McClain
J. Scott Gabrielsen, … , William T. Cefalu, Donald A. McClain
Published September 10, 2012
Citation Information: J Clin Invest. 2012;122(10):3529-3540. https://doi.org/10.1172/JCI44421.
View: Text | PDF
Research Article Metabolism

Adipocyte iron regulates adiponectin and insulin sensitivity

  • Text
  • PDF
Abstract

Iron overload is associated with increased diabetes risk. We therefore investigated the effect of iron on adiponectin, an insulin-sensitizing adipokine that is decreased in diabetic patients. In humans, normal-range serum ferritin levels were inversely associated with adiponectin, independent of inflammation. Ferritin was increased and adiponectin was decreased in type 2 diabetic and in obese diabetic subjects compared with those in equally obese individuals without metabolic syndrome. Mice fed a high-iron diet and cultured adipocytes treated with iron exhibited decreased adiponectin mRNA and protein. We found that iron negatively regulated adiponectin transcription via FOXO1-mediated repression. Further, loss of the adipocyte iron export channel, ferroportin, in mice resulted in adipocyte iron loading, decreased adiponectin, and insulin resistance. Conversely, organismal iron overload and increased adipocyte ferroportin expression because of hemochromatosis are associated with decreased adipocyte iron, increased adiponectin, improved glucose tolerance, and increased insulin sensitivity. Phlebotomy of humans with impaired glucose tolerance and ferritin values in the highest quartile of normal increased adiponectin and improved glucose tolerance. These findings demonstrate a causal role for iron as a risk factor for metabolic syndrome and a role for adipocytes in modulating metabolism through adiponectin in response to iron stores.

Authors

J. Scott Gabrielsen, Yan Gao, Judith A. Simcox, Jingyu Huang, David Thorup, Deborah Jones, Robert C. Cooksey, David Gabrielsen, Ted D. Adams, Steven C. Hunt, Paul N. Hopkins, William T. Cefalu, Donald A. McClain

×

Figure 6

Phlebotomy improves glucose tolerance.

Options: View larger image (or click on image) Download as PowerPoint
Phlebotomy improves glucose tolerance.
Human men with impaired glucose t...
Human men with impaired glucose tolerance and serum ferritin levels in the highest quartile of normal underwent phlebotomy to decrease their ferritin values to the lowest quartile of normal. (A) Results of oral glucose tolerance testing before (open symbols) and approximately 6 months after initiation of phlebotomy (closed symbols). The integrated area under the glucose curve for the 120-minute test is shown. Squares represent individual values, and circles represent the means. (*P < 0.03 by paired t test). (B) Insulin secretory capacity (AIRg) and (C) Si were determined from FSIVGTT performed before and after phlebotomy. (D) The disposition index was calculated from the data in B and C. *P < 0.05 by paired t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts